What is First Tracks Biotherapeutics Inc's net income?

First Tracks Biotherapeutics Inc (TRAX) reported net income of -$50.48M in Q1 2026.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Screener

Exxon MobilXOM

$4.18B-45.8%

VeradermicsMANE

-$27.23M-120%

GPA

General Purpose Acquisition Corp.GPAC

-$5.23M-37.4%

GPA

General Purpose Acquisition Corp.GPAC

-$5.23M-37.4%

Polaryx Therapeutics, Inc.PLYX

-$2.54M+49.6%

Polaryx Therapeutics, Inc.PLYX

-$2.54M+49.6%

Reported directly by First Tracks Biotherapeutics Inc in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026. Open the filing →

What is First Tracks Biotherapeutics Inc's net income?: First Tracks Biotherapeutics Inc (TRAX) reported net income of -$50.48M in Q1 2026.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.

Connect your AI assistant and compare it to peers, right in your chat.